| 000 | 01744 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516051007.0 | ||
| 264 | 0 | _c20120112 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1537-6591 | ||
| 024 | 7 |
_a10.1093/cid/cir406 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJacobson, Karen R | |
| 245 | 0 | 0 |
_aTreatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South Africa. _h[electronic resource] |
| 260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cAug 2011 |
||
| 300 |
_a369-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntitubercular Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBacterial Proteins _xgenetics |
| 650 | 0 | 4 |
_aCatalase _xgenetics |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoniazid _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTuberculosis _xdrug therapy |
| 650 | 0 | 4 | _aTuberculosis, Multidrug-Resistant |
| 700 | 1 | _aTheron, Danie | |
| 700 | 1 | _aVictor, Thomas C | |
| 700 | 1 | _aStreicher, Elizabeth M | |
| 700 | 1 | _aWarren, Robin M | |
| 700 | 1 | _aMurray, Megan B | |
| 773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 53 _gno. 4 _gp. 369-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/cid/cir406 _zAvailable from publisher's website |
| 999 |
_c21056210 _d21056210 |
||